SKIL and lung carcinoma: Although the precise mechanism linking SnON with all of these features is not clear, it is known to interact with SMADs to prevent TGF-β signalling [44], and previous studies demonstrated TGF-β-driven downregulation of E-cadherin and F-actin reorganisation in a SnON-knockdown lung cancer cell line [39].